Kindred Biosciences

$4.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.00%) As of 3:41 PM UTC today

Why Robinhood?

You can buy or sell KIN and other stocks, options, and ETFs commission-free!

About KIN

Kindred Biosciences, Inc. Common Stock, also called Kindred Biosciences, is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets.

CEO
Richard H. Chin
Employees
63
Headquarters
Burlingame, California
Founded
2012
Market Cap
196.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
706.04K
High Today
$5.00
Low Today
$4.82
Open Price
$5.00
Volume
52.17K
52 Week High
$6.00
52 Week Low
$3.20

KIN Earnings

-$0.45
-$0.10
$0.25
$0.60
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

YCL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure